William J. Gradishar, MD, on Atezolizumab and Nab-paclitaxel in Triple-Negative Breast Cancer

Posted: Monday, June 10, 2019

Based on the IMpassion130 trial, which patients with triple-negative breast cancer would you most likely consider for treatment with the combination of atezolizumab and nab-paclitaxel?